HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,124 | +7.8% | 34,872 | +2.5% | 0.02% | +10.5% |
| Q2 2023 | $2,898 | +1.4% | 34,035 | -1.5% | 0.02% | 0.0% |
| Q1 2023 | $2,859 | +15.8% | 34,549 | +10.1% | 0.02% | +5.6% |
| Q4 2022 | $2,469 | -99.9% | 31,386 | +30.6% | 0.02% | +38.5% |
| Q3 2022 | $1,779,000 | +233.1% | 24,035 | +193.5% | 0.01% | +225.0% |
| Q2 2022 | $534,000 | -19.0% | 8,189 | -21.5% | 0.00% | +33.3% |
| Q1 2022 | $659,000 | +24.8% | 10,431 | +4.8% | 0.00% | +50.0% |
| Q4 2021 | $528,000 | -8.7% | 9,957 | +21.6% | 0.00% | -33.3% |
| Q3 2021 | $578,000 | +30.2% | 8,186 | +22.8% | 0.00% | +50.0% |
| Q2 2021 | $444,000 | -29.5% | 6,666 | +17.5% | 0.00% | -50.0% |
| Q1 2021 | $630,000 | +14.8% | 5,672 | +22.6% | 0.00% | +33.3% |
| Q4 2020 | $549,000 | +117.0% | 4,626 | +59.7% | 0.00% | +50.0% |
| Q3 2020 | $253,000 | -64.1% | 2,896 | -52.9% | 0.00% | -60.0% |
| Q3 2018 | $705,000 | -27.5% | 6,149 | -43.3% | 0.01% | -16.7% |
| Q2 2018 | $972,000 | +13.8% | 10,839 | -7.1% | 0.01% | 0.0% |
| Q1 2018 | $854,000 | -19.2% | 11,670 | -35.8% | 0.01% | -14.3% |
| Q4 2017 | $1,057,000 | +415.6% | 18,191 | +156.9% | 0.01% | +600.0% |
| Q2 2016 | $205,000 | -5.5% | 7,081 | +13.9% | 0.00% | 0.0% |
| Q1 2016 | $217,000 | +42.8% | 6,216 | +32.3% | 0.00% | 0.0% |
| Q4 2015 | $152,000 | -25.9% | 4,700 | -25.8% | 0.00% | -50.0% |
| Q3 2015 | $205,000 | +147.0% | 6,336 | +217.1% | 0.00% | +100.0% |
| Q2 2015 | $83,000 | -95.6% | 1,998 | -95.2% | 0.00% | -93.3% |
| Q1 2015 | $1,867,000 | +3119.0% | 41,556 | +2569.0% | 0.02% | – |
| Q4 2014 | $58,000 | -12.1% | 1,557 | -17.0% | 0.00% | -100.0% |
| Q3 2014 | $66,000 | -2.9% | 1,876 | -2.1% | 0.00% | 0.0% |
| Q2 2014 | $68,000 | +9.7% | 1,917 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $62,000 | -23.5% | 1,917 | -0.1% | 0.00% | 0.0% |
| Q4 2013 | $81,000 | -69.0% | 1,918 | -70.7% | 0.00% | -50.0% |
| Q3 2013 | $261,000 | +80.0% | 6,554 | +86.4% | 0.00% | +100.0% |
| Q2 2013 | $145,000 | – | 3,517 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |